Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Using index levels to time market involves aligning trades with key thresholds while avoiding over-interpretation of minor moves.
28,495 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
A wealth manager reduced its position in FIXD by 86,075 shares, cutting the value by roughly $3.8 million. This artic...
A senior executive recently reduced his stake in CATY by one third through an open market sale. This article explains...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
Crypto ownership is now a visible factor in loan underwriting. Banks, insurers and regulators are racing to standardi...
A sharp intraday slide in D-Wave Quantum shares has many investors rattled. This guide breaks down what caused the mo...
AI momentum has pushed markets higher, but one stock stands out as a potential tech stock with eyes. This piece break...
When markets swing, investors ask if XRP is the best crypto right now. This guide breaks down what that label means, ...
As XRP trades near $1 in mid-2026, investors weigh the odds of a $100 price within five years as Ripple scales its pa...
Retirees face a tough choice as Netflix and T-Mobile trade lower on the year. This analysis weighs dividends, cash fl...
Toast is showing renewed momentum as its growth engine—international expansion, a growing enterprise pipeline, and a ...